Chinese lung cancer study for a rare type
Part of Cancer, Lungs & breathing clinical trials.
This study is collecting information from people with a rare lung cancer called pulmonary lymphoepithelioma-like carcinoma (a type of lung tumor that looks like certain head and neck cancers). It aims to learn more about the disease and how to better treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with primary pulmonary lymphoepithelioma-like carcinoma (a rare lung cancer).
- You do not have a head and neck cancer that has spread (metastatic nasopharyngeal carcinoma).
- You do not have serious heart, liver, or kidney disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects tissue samples from your lung tumor and any tumors that have spread to other parts of your body. They will study the genetic makeup of these samples to better understand lung cancer and improve future treatments.
This study looks at genetic changes in people with suspected or high-risk lung cancer. It aims to use those results to guide more personalized treatment decisions.
This trial looks at the “molecular landscape,” meaning the specific gene changes driving your lung cancer, for people whose non-small cell lung cancer (NSCLC) has rare mutations. The goal is to better understand what those rare changes mean and how they could guide treatment decisions.
This study analyzes genetic information from blood samples in patients with advanced lung cancer, head and neck cancer, or mesothelioma who are starting chemotherapy and immunotherapy. Understanding your cancer's genetics may help doctors personalize treatment and improve outcomes.
This study collects and analyzes lung cancer tissue samples to understand genetic differences that may help guide future treatment. You'll provide a tissue sample (either from a biopsy or prior surgery), and researchers will study it—no treatment is given in this study.
This study collects tissue (and follows patients over time) to better understand the natural course of several types of chest cancers. It may help researchers learn which tests and treatments work best in different cancer types.
Hear when a new Primary Pulmonary Lymphoepithelioma-like Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.